NO20002967D0 - Uretans derived from azacycloalkanes, thio and dithio analogues, and their preparation and use as 2,3 epoxysqualene-lanesterol cyclase inhibitor - Google Patents

Uretans derived from azacycloalkanes, thio and dithio analogues, and their preparation and use as 2,3 epoxysqualene-lanesterol cyclase inhibitor

Info

Publication number
NO20002967D0
NO20002967D0 NO20002967A NO20002967A NO20002967D0 NO 20002967 D0 NO20002967 D0 NO 20002967D0 NO 20002967 A NO20002967 A NO 20002967A NO 20002967 A NO20002967 A NO 20002967A NO 20002967 D0 NO20002967 D0 NO 20002967D0
Authority
NO
Norway
Prior art keywords
uretans
lanesterol
epoxysqualene
azacycloalkanes
thio
Prior art date
Application number
NO20002967A
Other languages
Norwegian (no)
Other versions
NO20002967L (en
Inventor
Roland Maier
Peter Mueller
Gebhard Schilcher
Gebhard Adelgoss
Rudolf Hurnaus
Michael Mark
Bernhard Eisele
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20002967D0 publication Critical patent/NO20002967D0/en
Publication of NO20002967L publication Critical patent/NO20002967L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • A23K20/132Heterocyclic compounds containing only one nitrogen as hetero atom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/70Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75Feeding-stuffs specially adapted for particular animals for birds for poultry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
  • Hydrogenated Pyridines (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20002967A 1997-12-10 2000-06-09 Uretans derived from azacycloalkanes, thio and dithio analogues, as well as the use and preparation of 2,3 eposkysqualene-lanesterol cyclase inhibitor NO20002967L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19754796A DE19754796A1 (en) 1997-12-10 1997-12-10 Novel azacycloalkane-derived urethanes, their thio and dithio analogues, their salts, pharmaceutical compositions containing them and their use, and processes for their preparation
PCT/EP1998/007965 WO1999029669A1 (en) 1997-12-10 1998-12-08 Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors

Publications (2)

Publication Number Publication Date
NO20002967D0 true NO20002967D0 (en) 2000-06-09
NO20002967L NO20002967L (en) 2000-08-09

Family

ID=7851381

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002967A NO20002967L (en) 1997-12-10 2000-06-09 Uretans derived from azacycloalkanes, thio and dithio analogues, as well as the use and preparation of 2,3 eposkysqualene-lanesterol cyclase inhibitor

Country Status (27)

Country Link
EP (1) EP1060162B1 (en)
JP (1) JP3418688B2 (en)
KR (1) KR20010032977A (en)
CN (1) CN1281434A (en)
AR (1) AR017827A1 (en)
AT (1) ATE234816T1 (en)
AU (1) AU1759499A (en)
BG (1) BG104500A (en)
BR (1) BR9813495A (en)
CA (1) CA2309388A1 (en)
CO (1) CO5370694A1 (en)
DE (2) DE19754796A1 (en)
DK (1) DK1060162T3 (en)
EA (1) EA200000631A1 (en)
EE (1) EE200000342A (en)
ES (1) ES2190130T3 (en)
HR (1) HRP20000377A2 (en)
HU (1) HUP0100335A3 (en)
IL (1) IL135738A0 (en)
NO (1) NO20002967L (en)
PL (1) PL341060A1 (en)
PT (1) PT1060162E (en)
SK (1) SK8612000A3 (en)
TR (1) TR200001635T2 (en)
WO (1) WO1999029669A1 (en)
YU (1) YU35600A (en)
ZA (1) ZA9811262B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077654A1 (en) * 2001-01-15 2004-04-22 Bouillot Anne Marie Jeanne Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
WO2002055495A1 (en) * 2001-01-15 2002-07-18 Glaxo Group Limited Aryl piperidine derivatives as inducers of ldl-receptor expression
EP1351937A1 (en) * 2001-01-15 2003-10-15 Glaxo Group Limited Aryl piperidine derivatives as inducers of ldl-receptor expression
DE10132686A1 (en) * 2001-07-05 2003-01-16 Boehringer Ingelheim Pharma Heteroarylcarboxamides, their preparation and their use as medicines
JP4664634B2 (en) * 2003-09-05 2011-04-06 富山化学工業株式会社 Novel benzamidine derivatives or salts thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04312572A (en) * 1991-04-12 1992-11-04 Takeda Chem Ind Ltd Cyclic amine compound
DE4407136A1 (en) * 1994-03-04 1995-09-07 Thomae Gmbh Dr K New amino:methyl substd. aroyl-aza:cycloalkane derivs.
DE4407138A1 (en) * 1994-03-04 1995-09-07 Thomae Gmbh Dr K Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, pharmaceutical compositions containing them and their use, and processes for their preparation

Also Published As

Publication number Publication date
SK8612000A3 (en) 2000-11-07
AU1759499A (en) 1999-06-28
DE59807591D1 (en) 2003-04-24
JP3418688B2 (en) 2003-06-23
PL341060A1 (en) 2001-03-26
TR200001635T2 (en) 2000-11-21
HUP0100335A3 (en) 2001-11-28
CO5370694A1 (en) 2004-02-27
WO1999029669A1 (en) 1999-06-17
DE19754796A1 (en) 1999-06-17
NO20002967L (en) 2000-08-09
EP1060162B1 (en) 2003-03-19
ES2190130T3 (en) 2003-07-16
PT1060162E (en) 2003-08-29
ATE234816T1 (en) 2003-04-15
HRP20000377A2 (en) 2000-12-31
JP2001525397A (en) 2001-12-11
ZA9811262B (en) 2000-06-09
KR20010032977A (en) 2001-04-25
YU35600A (en) 2002-09-19
EE200000342A (en) 2001-08-15
EA200000631A1 (en) 2000-12-25
IL135738A0 (en) 2001-05-20
BG104500A (en) 2001-03-30
CA2309388A1 (en) 1999-06-17
CN1281434A (en) 2001-01-24
BR9813495A (en) 2000-10-10
HUP0100335A2 (en) 2001-07-30
AR017827A1 (en) 2001-10-24
DK1060162T3 (en) 2003-07-14
EP1060162A1 (en) 2000-12-20

Similar Documents

Publication Publication Date Title
DK0832082T3 (en) N-heteroaryl-pyridine sulfonamide derivatives and their use as endothelin antagonists
IS5744A (en) New 3-aryl-propionic acid derivatives and analogues
FI956228L (en) Compositions intended for inhalation
DK1028961T3 (en) Pleuromutiline derivatives as antimicrobial agents
DE69835557D1 (en) Aqueous ink compositions
NO994906L (en) GnRH antagonists modified at positions 5 and 6
DK1015434T3 (en) New pyrimidin-4-one and pyrimidin-4-thione as fungicide
DK0609734T3 (en) Substituted triazolinones as well as their use as herbicides
PT946100E (en) HERBICIDAL COMPOSITIONS CONTAINING N-¬ (4,6-DIMETOXYPYRIMIDIN-2-YL) AMINOCARBONYL-5-METHYLSULFONAMIDOMETHYL-2-ALCOXYCARBONYLENZENESULFONAMIDES
NO996115L (en) Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists
ATE212635T1 (en) 1,3,8-TRIAZASPIRO(4,5)DECAN-4-ON DERIVATIVES
DE69812371D1 (en) FUNGICIDE COMBINATIONS CONTAINING PHENYLACRYLIC ACID DERIVATIVES
NO20003105L (en) Phenylaminoalkylcarboxylic acid derivatives as well as medical compositions comprising such
FI972306A7 (en) Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one-1,1-dioxide derivatives and compositions containing them and methods for using them
NO20002967D0 (en) Uretans derived from azacycloalkanes, thio and dithio analogues, and their preparation and use as 2,3 epoxysqualene-lanesterol cyclase inhibitor
DE69805242D1 (en) titanium aluminide
DK0906293T3 (en) Substituted sulfonylamino (thio) carbonyl compounds as well as their use as herbicides
FI941149L (en) 2,4-diamino-3-hydroxycarboxylic acid derivatives
NO996244D0 (en) Pyrrolidinecarboxylic acid derivatives as endothelin antagonists
NO972905D0 (en) Tenoxasinon derivatives useful as antiviral agents
DE59800203D1 (en) Drill, screwdriver or impact drill
SI1060162T1 (en) Urethanes derived from azacycloalkanes, their thio and dithio analogues, their preparation and their use as inhibitors of 2,3-epoxyskvalen-lanesterol cyclase
NO20005756L (en) Carboxy-substituted carboxamide derivatives as tachykinin antagonists
EE200000340A (en) Novel urethanes, their thio and dithio analogs, their salts, medicaments containing them and their use, as well as the method for their preparation
FI960051L (en) Difluorostatin analogues

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application